What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Acquired immunodeficiency syndrome
- Virus
Internal medicine, Immunology, Virology, Hepatitis C virus and Ribavirin are his primary areas of study.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Ledipasvir, Surgery and Sofosbuvir.
His work on Viral disease, Immunopathology and Virus as part of general Immunology study is frequently linked to Circulating MicroRNA, therefore connecting diverse disciplines of science.
His Virology research is multidisciplinary, relying on both Pharmacogenetics, Efavirenz and Acquired immunodeficiency syndrome.
Stefan Mauss interconnects Hepatitis B, Malignancy and Hepatitis in the investigation of issues within Acquired immunodeficiency syndrome.
His study in Hepatitis C virus is interdisciplinary in nature, drawing from both Liver disease, Hepatitis C, Disease and Intensive care medicine.
His most cited work include:
- Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
- Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study (981 citations)
- Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study (436 citations)
What are the main themes of his work throughout his whole career to date?
Stefan Mauss mainly focuses on Internal medicine, Ribavirin, Gastroenterology, Hepatitis C and Virology.
The study incorporates disciplines such as Chronic hepatitis, Immunology and Hepatitis C virus in addition to Internal medicine.
His Immunology study frequently intersects with other fields, such as Acquired immunodeficiency syndrome.
In the field of Ribavirin, his study on Peginterferon alfa-2a, Hcv genotype 1, Pegylated interferon and Telaprevir overlaps with subjects such as PEG ratio.
His work focuses on many connections between Gastroenterology and other disciplines, such as Adverse effect, that overlap with his field of interest in Clinical trial.
His research integrates issues of Surgery, Cirrhosis, Viral load, Sofosbuvir and Hepatitis in his study of Hepatitis C.
He most often published in these fields:
- Internal medicine (62.02%)
- Ribavirin (37.09%)
- Gastroenterology (34.12%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (62.02%)
- Hepatitis C (28.19%)
- Hepatitis C virus (16.32%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Hepatitis C, Hepatitis C virus, Gastroenterology and Cohort.
His work in Internal medicine addresses issues such as Chronic hepatitis, which are connected to fields such as Weight gain.
His Hepatitis C study combines topics in areas such as Virus, Pibrentasvir, Regimen and Glecaprevir.
Hepatitis C virus is a subfield of Virology that Stefan Mauss tackles.
His Virology research integrates issues from Epidemiology and Treatment failure.
His biological study spans a wide range of topics, including Elbasvir, Grazoprevir, Ribavirin, Sofosbuvir and Fibrosis.
Between 2017 and 2021, his most popular works were:
- Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study (436 citations)
- Direct‐acting antiviral treatment of chronic HCV‐infected patients on opioid substitution therapy: Still a concern in clinical practice? (38 citations)
- Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection. (37 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Acquired immunodeficiency syndrome
- Virus
Stefan Mauss mostly deals with Internal medicine, Hepatitis C virus, Hepatitis C, Hepatitis and Cohort.
His Internal medicine research focuses on Gastroenterology and how it connects with Fibrosis.
His Hepatitis C virus research is classified as research in Virology.
In his study, Immunology, Tolerability and Glecaprevir is strongly linked to Regimen, which falls under the umbrella field of Hepatitis.
His studies deal with areas such as Odds ratio, Diabetes mellitus, Acquired immunodeficiency syndrome, Hazard ratio and Risk factor as well as Cohort.
His Sofosbuvir course of study focuses on Ledipasvir and Clinical significance and Viral load.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
